We therefore conclude that HGF-positive stem cells detected in UIP may rather be antifibrotic and therefore HGF-modified BMSC might represent a novel therapeutic strategy in patients with UIP/IPF in the future. Here, HGF is linked to idiopathic pulmonary fibrosis.